FATE THERAPEUTICS INC - FATE

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q2 2026 · Q1 2026

Value (USD)

Total reported value ($000)

$194.4M

QoQ value delta ($000)

+$105.4M (+118.38%)

Implied price effect (QoQ)

+124.72%

Total shares

72,173,219

QoQ shares delta

-2,096,372 (-2.82%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q2 2026 data: 157 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
Redmile Group, LLC	34,756	12,872,946	2.33%
BlackRock, Inc.	19,707	7,298,895	0.0%
VANGUARD PORTFOLIO MANAGEMENT LLC	12,273	4,545,893	0.0%
VANGUARD CAPITAL MANAGEMENT LLC	12,002	4,445,536	0.0%
ACADIAN ASSET MANAGEMENT LLC	11,742	4,351,250	0.01%
AQR CAPITAL MANAGEMENT LLC	10,360	3,837,229	0.0%
TWO SIGMA INVESTMENTS, LP	9,692	3,589,863	0.01%
JOHNSON & JOHNSON	9,123	3,379,064	1.14%
RENAISSANCE TECHNOLOGIES LLC	8,054	2,983,268	0.01%
MILLENNIUM MANAGEMENT LLC	6,571	2,433,978	0.0%
GOLDMAN SACHS GROUP INC	5,532	2,049,187	0.0%
GEODE CAPITAL MANAGEMENT, LLC	3,571	1,322,013	0.0%
JANE STREET GROUP, LLC	3,027	1,121,407	0.0%
CITADEL ADVISORS LLC	2,952	1,093,608	0.0%
T. Rowe Price Investment Management, Inc.	2,917	1,080,320	0.0%
Bruce & Co., Inc.	2,670	989,188	0.72%
MORGAN STANLEY	1,875	694,580	0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP	1,814	672,050	0.0%
VANGUARD FIDUCIARY TRUST CO	1,729	640,428	0.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	1,649	610,949	0.0%
UBS Group AG	1,593	590,178	0.0%
Qube Research & Technologies Ltd	1,561	578,150	0.0%
Connor, Clark & Lunn Investment Management Ltd.	1,552	574,995	0.0%
STATE STREET CORP	1,509	558,928	0.0%
DAFNA Capital Management LLC	1,417	525,000	0.27%